, Tracking Stock Market Picks
Enter Symbol:

Neutral VRUS
up 1,126.79 %

PHARMASSET INC. (VRUS) downgraded to Neutral with price target $137 by Robert W. Baird

Posted on: Friday,  Dec 16, 2011  11:25 AM ET by Robert W. Baird

Robert W. Baird rated Neutral PHARMASSET INC. (NASDAQ: VRUS) on 12/16/2011. Previously Robert W. Baird rated Outperform PHARMASSET INC. (NASDAQ: VRUS) on
09/08/2009., when the stock price was $10.15. Since then, PHARMASSET INC. has gained 1126.80% as of 12/16/2011's recent price of $124.52.
If you would have followed the previous Robert W. Baird's recommendation on VRUS, you would have gained 1126.79% of your investment in 829 days.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/16/2011 11:25 AM Hold
124.52 137.00
as of 12/30/2011
1 Week   
1 Month down  -4.93 %
3 Months up  51.17 %
1 YTD up  471.71 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/8/2009 8:25 AM Buy
10.15 15.00
4/16/2008 8:25 AM Hold
8.51 10.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy